Pharmacoeconomic analysis of dexamethasone intravitreal implant for the treatment of diabetic macular edema in Russia
A health economic study was conducted under the Russian economic conditions to evaluate the feasibility of the use of dexamethasone 0.7 mg as a sustained release intravitreal implant (hereinafter, DEX implant) in the treatment of diabetic macular edema. Cost-effectiveness analyses (CEA) were perform...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Izdatelstvo OKI
2018-06-01
|
| Serija: | Качественная клиническая практика |
| Teme: | |
| Online dostop: | https://www.clinvest.ru/jour/article/view/216 |
| Oznake: |
Brez oznak, prvi označite!
|